Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
Authors
Keywords
brain tumors, microRNA, long noncoding RNA, mutations, epigenetics, gene editing.
Journal
Neurotherapeutics
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-15
DOI
10.1007/s13311-018-00702-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ETS-1 Expression Is Hypoxia-independent in Glioblastoma-derived Endothelial and Mesenchymal Stem-like Cells
- (2018) DOMINIK KOESSINGER et al. ANTICANCER RESEARCH
- Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)
- (2018) Jonathan E. Rosenberg et al. BRITISH JOURNAL OF CANCER
- Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization
- (2018) Theresa Barberi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth
- (2018) Guanjian Zhao et al. CANCER LETTERS
- Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression
- (2018) Zhiyun Yu et al. CANCER LETTERS
- CRISPR/Cas9-mediated knockout of DGK improves anti-tumor activities of human T cells
- (2018) In-Young Jung et al. CANCER RESEARCH
- Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44
- (2018) Tadas K. Rimkus et al. CANCER RESEARCH
- Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
- (2018) Alexander D. Barrow et al. CELL
- When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM
- (2018) Saumya R. Bollam et al. Current Neurology and Neuroscience Reports
- Therapeutic Potential of Small Activating RNAs (saRNAs) in Human cancers
- (2018) Sorah Yoon et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Zeb1 potentiates genome‐wide gene transcription with Lef1 to promote glioblastoma cell invasion
- (2018) Pedro Rosmaninho et al. EMBO JOURNAL
- HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma
- (2018) Shu Li et al. FEBS Journal
- Acetyl-CoA promotes glioblastoma cell adhesion and migration through Ca2+–NFAT signaling
- (2018) Joyce V. Lee et al. GENES & DEVELOPMENT
- MiR-15b/HOTAIR/p53 form a regulatory loop that affects the growth of glioma cells
- (2018) Guan Sun et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote glioma progression by sponging miR-126-5p
- (2018) Liang Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Voltage-gated potassium channel blocker 4-aminopyridine induces glioma cell apoptosis by reducing expression of microRNA-10b-5p
- (2018) Qin Ru et al. MOLECULAR BIOLOGY OF THE CELL
- New insights into long noncoding RNAs and their roles in glioma
- (2018) Zixuan Peng et al. Molecular Cancer
- Efficient Gene Silencing in Brain Tumors with Hydrophobically Modified siRNAs
- (2018) Maire F. Osborn et al. MOLECULAR CANCER THERAPEUTICS
- Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma
- (2018) Andrei M. Mikheev et al. Molecular Oncology
- Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma
- (2018) Katarzyna C. Pituch et al. MOLECULAR THERAPY
- Clinical utility of circulating non-coding RNAs — an update
- (2018) Simone Anfossi et al. Nature Reviews Clinical Oncology
- Multidimensional communication in the microenvirons of glioblastoma
- (2018) Marike L. Broekman et al. Nature Reviews Neurology
- The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma
- (2018) Guillermo Aldave et al. NEURO-ONCOLOGY
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells
- (2018) Zhi-Chuan Zhu et al. ONCOGENE
- Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
- (2018) Zhenyi An et al. ONCOGENE
- YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity
- (2018) Olivia M. Yu et al. ONCOGENE
- Long non-coding RNA H19 promotes proliferation and invasion in human glioma cells by downregulating miR-152
- (2018) Lei Chen et al. ONCOLOGY RESEARCH
- High-level Sp1 is Associated with Proliferation, Invasion, and Poor Prognosis in Astrocytoma
- (2018) Yi-Ting Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma
- (2018) Ayguen Sahin et al. PLoS One
- Anti-miRNA oligonucleotides: A comprehensive guide for design
- (2018) Joana Filipa Lima et al. RNA Biology
- An anatomic transcriptional atlas of human glioblastoma
- (2018) Ralph B. Puchalski et al. SCIENCE
- Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy
- (2018) Serena Pellegatta et al. Science Translational Medicine
- The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway
- (2018) Linwei Jia et al. OncoTargets and Therapy
- Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing
- (2018) Aamir Mir et al. Nature Communications
- Dose-Dependent Lowering of Mutant Huntingtin Using Antisense Oligonucleotides in Huntington Disease Patients
- (2018) Willeke M.C. van Roon-Mom et al. Nucleic Acid Therapeutics
- The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma
- (2018) Debolina Ganguly et al. Oncotarget
- The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter
- (2018) Barbara Fazi et al. Oncotarget
- TRAF3IP2, a novel therapeutic target in glioblastoma multiforme
- (2018) Eckhard U. Alt et al. Oncotarget
- Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide)
- (2018) Arshad A. Pandith et al. Scientific Reports
- A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
- (2018) Jonathan D. Finn et al. Cell Reports
- Activity of Metabotropic Glutamate Receptor 4 Suppresses Proliferation and Promotes Apoptosis With Inhibition of Gli-1 in Human Glioblastoma Cells
- (2018) Zhichao Zhang et al. Frontiers in Neuroscience
- STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
- (2018) Carla Lucia Esposito et al. Molecular Therapy-Nucleic Acids
- Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells
- (2018) Amy E. Arnold et al. Molecular Therapy-Nucleic Acids
- Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
- (2018) Anandani Nellan et al. Journal for ImmunoTherapy of Cancer
- Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
- (2018) Ramona Schulz-Heddergott et al. Cancers
- Ivosidenib: First Global Approval
- (2018) Sohita Dhillon DRUGS
- Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial
- (2018) Matteo S. Carlino et al. EUROPEAN JOURNAL OF CANCER
- PEI-Coated Fe3O4 Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells
- (2018) Rui Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
- (2018) Yelena Y. Janjigian et al. JOURNAL OF CLINICAL ONCOLOGY
- Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132
- (2018) Ke Zhou et al. Molecular Cancer
- Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ
- (2018) Zhijun Liu et al. ONCOGENE
- PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
- (2018) Tianrun Liu et al. Nature Communications
- A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine
- (2018) Hyun Jung Jun et al. Nature Communications
- A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
- (2018) Xiaoyue Chen et al. Nature Communications
- Argonaute and the Nuclear RNAs: New Pathways for RNA-Mediated Control of Gene Expression
- (2018) Keith T. Gagnon et al. Nucleic Acid Therapeutics
- Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma—A phase II multicentric, randomised study
- (2017) Renata Ursu et al. EUROPEAN JOURNAL OF CANCER
- Mutant p53 as a target for cancer treatment
- (2017) Michael J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity
- (2017) Ciro Zanca et al. GENES & DEVELOPMENT
- RNA processing as an alternative route to attack glioblastoma
- (2017) Fabiana Marcelino Meliso et al. HUMAN GENETICS
- MicroRNA-10b mediates TGF-β1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition
- (2017) Chengyuan Ma et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer
- (2017) Evan Y. Yu et al. INVESTIGATIONAL NEW DRUGS
- Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2
- (2017) Jia Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Overcoming therapeutic resistance in glioblastoma: the way forward
- (2017) Satoru Osuka et al. JOURNAL OF CLINICAL INVESTIGATION
- Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier
- (2017) Ilaria Monaco et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
- (2017) Xuetian Yue et al. JOURNAL OF MOLECULAR BIOLOGY
- MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor
- (2017) Yunxiang Chen et al. JOURNAL OF NEURO-ONCOLOGY
- Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial
- (2017) Kim N Chi et al. LANCET ONCOLOGY
- Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial
- (2017) Tomasz M Beer et al. LANCET ONCOLOGY
- RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials
- (2017) Eunice L. Lozada-Delgado et al. LIFE SCIENCES
- Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b
- (2017) Rachid El Fatimy et al. MOLECULAR THERAPY
- RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
- (2017) Tae Jin Lee et al. MOLECULAR THERAPY
- Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
- (2017) Tyler E. Miller et al. NATURE
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- Oligonucleotide therapies for disorders of the nervous system
- (2017) Olga Khorkova et al. NATURE BIOTECHNOLOGY
- Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
- (2017) Hao Yin et al. NATURE BIOTECHNOLOGY
- A TNF–JNK–Axl–ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma
- (2017) Gao Guo et al. NATURE NEUROSCIENCE
- AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
- (2017) Ryan D Chow et al. NATURE NEUROSCIENCE
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas
- (2017) Frederick M Lang et al. NEURO-ONCOLOGY
- Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
- (2017) Kathleen M. Schoch et al. NEURON
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving CRISPR–Cas specificity with chemical modifications in single-guide RNAs
- (2017) Daniel E Ryan et al. NUCLEIC ACIDS RESEARCH
- Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells
- (2017) Xiao Zhang et al. NUCLEIC ACIDS RESEARCH
- KLF6 depletion promotes NF-κB signaling in glioblastoma
- (2017) A P Masilamani et al. ONCOGENE
- ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways
- (2017) F Wang et al. ONCOGENE
- Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis
- (2017) S Deguchi et al. ONCOGENE
- Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas
- (2017) D Yan et al. ONCOGENE
- Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation
- (2017) Aristotle Bamias et al. ONCOLOGIST
- A Randomized, Double‐Blinded, Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial
- (2017) Andrew H. Ko et al. ONCOLOGIST
- The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
- (2017) Ricardo Titze-de-Almeida et al. PHARMACEUTICAL RESEARCH
- Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression
- (2017) Dou Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glioma epigenetics: From subclassification to novel treatment options
- (2017) Olga Gusyatiner et al. SEMINARS IN CANCER BIOLOGY
- Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton’s Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity
- (2017) S. Sharif et al. Stem Cell Reviews and Reports
- Coding and noncoding landscape of extracellular RNA released by human glioma stem cells
- (2017) Zhiyun Wei et al. Nature Communications
- Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis
- (2017) Jia-Lin Huang et al. Nature Communications
- Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
- (2017) Anna C. Filley et al. Oncotarget
- Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer
- (2017) Ali R. Özeş et al. Scientific Reports
- Long Non-coding RNA XIST Promotes Glioma Tumorigenicity and Angiogenesis by Acting as a Molecular Sponge of miR-429
- (2017) Zhihua Cheng et al. Journal of Cancer
- Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton’s Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity
- (2017) S. Sharif et al. Stem Cell Reviews and Reports
- Knockdown of long non-coding RNA XIST increases blood–tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137
- (2017) H Yu et al. Oncogenesis
- Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
- (2017) Maria J. Williams et al. Frontiers in Oncology
- Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity
- (2017) Megan Basila et al. PLoS One
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
- (2016) Francis A.S. Lee et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Long non-coding RNA CCAT1 promotes glioma cell proliferation via inhibiting microRNA-410
- (2016) Zhao-Hui Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells
- (2016) Sonam Dolma et al. CANCER CELL
- Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a
- (2016) Peng Jia et al. CANCER LETTERS
- miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis
- (2016) Jianfei Xue et al. CANCER RESEARCH
- OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
- (2016) Alexander A. Svoronos et al. CANCER RESEARCH
- Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
- (2016) Baoli Hu et al. CELL
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic
- (2016) N. M. Teplyuk et al. EMBO Molecular Medicine
- Resetting cancer stem cell regulatory nodes upon MYC inhibition
- (2016) Silvia Galardi et al. EMBO REPORTS
- Emerging targeted therapies for glioma
- (2016) Julie J Miller et al. EXPERT OPINION ON EMERGING DRUGS
- Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer
- (2016) A.G. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing
- (2016) Melissa L. Kelley et al. JOURNAL OF BIOTECHNOLOGY
- A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells
- (2016) Carla L. Esposito et al. JOURNAL OF CONTROLLED RELEASE
- Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme
- (2016) Szu-Ting Chou et al. JOURNAL OF CONTROLLED RELEASE
- Optimization of in vivo DNA delivery with NickFect peptide vectors
- (2016) Krista Freimann et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases
- (2016) Cláudia Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Anti-cancer effect of R3V6 peptide-mediated delivery of an anti-microRNA-21 antisense-oligodeoxynucleotide in a glioblastoma animal model
- (2016) Binna Oh et al. JOURNAL OF DRUG TARGETING
- A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study
- (2016) Ralph Salloum et al. JOURNAL OF NEURO-ONCOLOGY
- Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
- (2016) Jie Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation
- (2016) Andrew J. Dodgshun et al. JOURNAL OF NEURO-ONCOLOGY
- Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells
- (2016) Xiaochun Jiang et al. JOURNAL OF NEUROSURGERY
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- Tailored Nanoparticle Codelivery of antimiR-21 and antimiR-10b Augments Glioblastoma Cell Kill by Temozolomide: Toward a “Personalized” Anti-microRNA Therapy
- (2016) Jeyarama S. Ananta et al. MOLECULAR PHARMACEUTICS
- CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis
- (2016) Jian Zheng et al. MOLECULAR THERAPY
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- PRMT5–PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells
- (2016) Y K Banasavadi-Siddegowda et al. ONCOGENE
- Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma
- (2016) H Cai et al. ONCOGENE
- Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma
- (2016) Suely Kazue Nagahashi Marie et al. Proteome Science
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
- (2016) D. F. Quail et al. SCIENCE
- Clinical trial of blood-brain barrier disruption by pulsed ultrasound
- (2016) Alexandre Carpentier et al. Science Translational Medicine
- Liposomal Spherical Nucleic Acids for Regulating Long Noncoding RNAs in the Nucleus
- (2016) Anthony J. Sprangers et al. Small
- Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling
- (2016) Y Han et al. Cell Death & Disease
- Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis
- (2016) Qi Cui et al. Nature Communications
- A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways
- (2016) Tianzhi Huang et al. Nature Communications
- Transcriptional silencing of long noncoding RNA GNG12-AS1 uncouples its transcriptional and product-related functions
- (2016) Lovorka Stojic et al. Nature Communications
- Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment
- (2016) Keisuke Katsushima et al. Nature Communications
- Identification of an Interfering Ligand Aptamer for EphB2/3 Receptors
- (2016) Paola Amero et al. Nucleic Acid Therapeutics
- c-MYC inhibition impairs hypoxia response in glioblastoma multiforme
- (2016) Maria Patrizia Mongiardi et al. Oncotarget
- Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis
- (2016) Brian J. Reon et al. PLOS MEDICINE
- AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin
- (2016) Ye Cheng et al. PLoS One
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Antisense oligonucleotides in therapy for neurodegenerative disorders
- (2015) Melvin M. Evers et al. ADVANCED DRUG DELIVERY REVIEWS
- Identification of a novel cell-penetrating peptide targeting human glioblastoma cell lines as a cancer-homing transporter
- (2015) Moritoshi Higa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles
- (2015) Shaobo Ruan et al. BIOMATERIALS
- MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin
- (2015) Marco Gallo et al. CANCER CELL
- CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling
- (2015) Yunliang Wang et al. CANCER LETTERS
- Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion
- (2015) Humsa S. Venkatesh et al. CELL
- miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics
- (2015) Fotini M Kouri et al. CELL CYCLE
- Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21
- (2015) Ping Wang et al. CELLULAR SIGNALLING
- A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
- (2015) A. Gulla et al. CLINICAL CANCER RESEARCH
- Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma
- (2015) Mateja Delač et al. CYTOMETRY PART A
- Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: In vitro analysis
- (2015) Matt Gooding et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Molecular targets in glioblastoma
- (2015) Maira Zorzan et al. Future Oncology
- miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma
- (2015) Fotini M. Kouri et al. GENES & DEVELOPMENT
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222
- (2015) ELEONORA BROGNARA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma
- (2015) Pedro M. Costa et al. JOURNAL OF CONTROLLED RELEASE
- RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma
- (2015) Philip J. Uren et al. MOLECULAR AND CELLULAR BIOLOGY
- NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma
- (2015) Hui Wang et al. Molecular Cancer
- Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222
- (2015) Xihe Zhao et al. MOLECULAR THERAPY
- The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma
- (2015) Hon-Kit Andus Wong et al. MOLECULAR THERAPY
- Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E
- (2015) Ana Rute Neves et al. NANOTECHNOLOGY
- Insulator dysfunction and oncogene activation in IDH mutant gliomas
- (2015) William A. Flavahan et al. NATURE
- Mechanisms of Long Non-coding RNAs in Mammalian Nervous System Development, Plasticity, Disease, and Evolution
- (2015) James A. Briggs et al. NEURON
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1
- (2015) I Vassallo et al. ONCOGENE
- Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines
- (2015) ZHAOHUI LI et al. ONCOLOGY REPORTS
- Knockdown of AKT3 and PI3KCA by RNA interference changes the expression of the genes that are related to apoptosis and autophagy in T98G glioblastoma multiforme cells
- (2015) Monika Paul-Samojedny et al. Pharmacological Reports
- Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression
- (2015) David Kozono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core
- (2015) Andrew J. Clark et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation
- (2015) Chiara Pastori et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma
- (2015) Nadiya M. Teplyuk et al. Oncotarget
- Transforming growth factor-β pathway activity in glioblastoma
- (2015) Karl Frei et al. Oncotarget
- Prolonged Ezh2 Depletion in Glioblastoma Causes a Robust Switch in Cell Fate Resulting in Tumor Progression
- (2015) Nienke A. de Vries et al. Cell Reports
- Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution
- (2015) Moran N Cabili et al. GENOME BIOLOGY
- Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response
- (2015) Frederick J. Sheedy Frontiers in Immunology
- MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1
- (2015) Ariel Bier et al. Oncotarget
- Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma
- (2015) Negar Babae et al. Oncotarget
- RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation
- (2015) Ming Yuan et al. Oncotarget
- microRNA-148a Is a Prognostic oncomiR That Targets MIG6 and BIM to Regulate EGFR and Apoptosis in Glioblastoma
- (2014) J. Kim et al. CANCER RESEARCH
- Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
- (2014) Mario L. Suvà et al. CELL
- Connect Four with Glioblastoma Stem Cell Factors
- (2014) Jan Gronych et al. CELL
- Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1
- (2014) J Bageritz et al. CELL DEATH AND DIFFERENTIATION
- Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
- (2014) A. Ruzsa et al. INVESTIGATIONAL NEW DRUGS
- MicroRNA-21 Promotes Glioblastoma Tumorigenesis by Down-regulating Insulin-like Growth Factor-binding Protein-3 (IGFBP3)
- (2014) Chuan He Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MiR-181a Regulates Blood-Tumor Barrier Permeability by Targeting Krüppel-Like Factor 6
- (2014) Jun Ma et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression
- (2014) Roberto Ferrarese et al. JOURNAL OF CLINICAL INVESTIGATION
- Dual Effect of CTCF Loss on Neuroprogenitor Differentiation and Survival
- (2014) L. A. Watson et al. JOURNAL OF NEUROSCIENCE
- Comparison of Five Peptide Vectors for Improved Brain Delivery of the Lysosomal Enzyme Arylsulfatase A
- (2014) A. Bockenhoff et al. JOURNAL OF NEUROSCIENCE
- Dacarbazine with or without oblimersen (a Bcl-2 antisense oligonucleotide) in chemotherapy-naive patients with advanced melanoma and low–normal serum lactate dehydrogenase
- (2014) Agop Y. Bedikian et al. MELANOMA RESEARCH
- A Functional Screen Identifies miRs That Induce Radioresistance in Glioblastomas
- (2014) P. Moskwa et al. MOLECULAR CANCER RESEARCH
- Towards a therapy for Angelman syndrome by targeting a long non-coding RNA
- (2014) Linyan Meng et al. NATURE
- Contemporary murine models in preclinical astrocytoma drug development
- (2014) Robert S. McNeill et al. NEURO-ONCOLOGY
- MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1
- (2014) Q. Chen et al. NEURO-ONCOLOGY
- Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
- (2014) P. Y. Wen et al. NEURO-ONCOLOGY
- MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma
- (2014) V Mucaj et al. ONCOGENE
- Arginine-rich, cell penetrating peptide–anti-microRNA complexes decrease glioblastoma migration potential
- (2014) Yu Zhang et al. PEPTIDES
- Genomic Analyses Reveal Broad Impact of miR-137 on Genes Associated with Malignant Transformation and Neuronal Differentiation in Glioblastoma Cells
- (2014) Saleh Tamim et al. PLoS One
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis
- (2014) Daniela Annibali et al. Nature Communications
- Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
- (2013) Eunhee Kim et al. CANCER CELL
- A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
- (2013) Anthony W. Tolcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial-Mesenchymal Transition and Suppresses Tumor Growth and Progression
- (2013) Z. Shi et al. CANCER RESEARCH
- Aptamer Identification of Brain Tumor-Initiating Cells
- (2013) Y. Kim et al. CANCER RESEARCH
- miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma
- (2013) Jun Wei et al. CANCER RESEARCH
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
- (2013) E Mogilyansky et al. CELL DEATH AND DIFFERENTIATION
- mir-17-92: a polycistronic oncomir with pleiotropic functions
- (2013) Virginie Olive et al. IMMUNOLOGICAL REVIEWS
- The NFL-TBS.40-63 anti-glioblastoma peptide enters selectively in glioma cells by endocytosis
- (2013) Claire Lépinoux-Chambaud et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Oncogenic effects of miR-10b in glioblastoma stem cells
- (2013) Fadila Guessous et al. JOURNAL OF NEURO-ONCOLOGY
- miR-124 radiosensitizes human glioma cells by targeting CDK4
- (2013) Xubin Deng et al. JOURNAL OF NEURO-ONCOLOGY
- Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III
- (2013) Michela Visani et al. Molecular Oncology
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- STAT3 silencing inhibits glioma single cell infiltration and tumor growth
- (2013) M. Priester et al. NEURO-ONCOLOGY
- MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells
- (2013) Pierpaolo Peruzzi et al. NEURO-ONCOLOGY
- Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome
- (2013) Shadi Lalezari et al. NEURO-ONCOLOGY
- Alternative Polyadenylation in Glioblastoma Multiforme and Changes in Predicted RNA Binding Protein Profiles
- (2013) Jiaofang Shao et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- DRR regulates AKT activation to drive brain cancer invasion
- (2013) A Dudley et al. ONCOGENE
- microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma
- (2013) Liwen An et al. PLoS One
- Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates
- (2013) C. H. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma
- (2013) L. K. Mathew et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
- (2013) David A. Nathanson et al. SCIENCE
- Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
- (2013) S. A. Jensen et al. Science Translational Medicine
- Targeting the Cytosolic Innate Immune Receptors RIG-I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in Glioblastoma
- (2013) Martin Glas et al. STEM CELLS
- Expression of dedifferentiation markers and multilineage markers in U251 glioblastoma cells with silenced EGFR and FGFR genes
- (2013) JUE XIE et al. Oncology Letters
- Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment
- (2013) Pedro M Costa et al. Molecular Therapy-Nucleic Acids
- Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts
- (2013) Masasuke Ohno et al. Journal for ImmunoTherapy of Cancer
- Endosomolytic Anionic Polymer for the Cytoplasmic Delivery of siRNAs in Localized In Vivo Applications
- (2012) Sariah Khormaee et al. ADVANCED FUNCTIONAL MATERIALS
- TGF-β as a therapeutic target in high grade gliomas – Promises and challenges
- (2012) Justin V. Joseph et al. BIOCHEMICAL PHARMACOLOGY
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β
- (2012) Matthew E. Hardee et al. CANCER RESEARCH
- MEF Promotes Stemness in the Pathogenesis of Gliomas
- (2012) Elena Bazzoli et al. Cell Stem Cell
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
- (2012) Marilena V. Iorio et al. EMBO Molecular Medicine
- miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2
- (2012) Lingchao Chen et al. EUROPEAN JOURNAL OF CANCER
- The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression
- (2012) T. Derrien et al. GENOME RESEARCH
- TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets
- (2012) Libing Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of Novel miR-21 Target Proteins in Multiple Myeloma Cells by Quantitative Proteomics
- (2012) Qian Xiong et al. JOURNAL OF PROTEOME RESEARCH
- High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
- (2012) Chunzhi Zhang et al. Journal of Translational Medicine
- Deletion or Epigenetic Silencing of AJAP1 on 1p36 in Glioblastoma
- (2012) N. Lin et al. MOLECULAR CANCER RESEARCH
- STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
- (2012) Shinji Kohsaka et al. MOLECULAR CANCER THERAPEUTICS
- IDH mutation impairs histone demethylation and results in a block to cell differentiation
- (2012) Chao Lu et al. NATURE
- MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity
- (2012) Hongping Xia et al. NEURO-ONCOLOGY
- MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity
- (2012) N. M. Teplyuk et al. NEURO-ONCOLOGY
- miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression
- (2012) W. Zhang et al. NEURO-ONCOLOGY
- Long non-coding RNA expression profiles predict clinical phenotypes in glioma
- (2012) Xiaoqin Zhang et al. NEUROBIOLOGY OF DISEASE
- MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1
- (2012) YANWEI LIU et al. ONCOLOGY REPORTS
- MiR-128 Inhibits Tumor Growth and Angiogenesis by Targeting p70S6K1
- (2012) Zhu-mei Shi et al. PLoS One
- Genome-Wide Profiling Identified a Set of miRNAs that Are Differentially Expressed in Glioblastoma Stem Cells and Normal Neural Stem Cells
- (2012) Ming-Fei Lang et al. PLoS One
- MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme
- (2012) J Lin et al. Cell Death & Disease
- Transposable elements reveal a stem cell-specific class of long noncoding RNAs
- (2012) David Kelley et al. GENOME BIOLOGY
- MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma
- (2011) Alfa H. C. Bai et al. ACTA NEUROPATHOLOGICA
- Context effect: microRNA-10b in cancer cell proliferation, spread and death
- (2011) Galina Gabriely et al. Autophagy
- Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
- (2011) Jianwei Guo et al. BIOMATERIALS
- MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10
- (2011) Lihua Sun et al. BRAIN RESEARCH
- A miR-21 inhibitor enhances apoptosis and reduces G2-M accumulation induced by ionizing radiation in human glioblastoma U251 cells
- (2011) Yi Li et al. Brain Tumor Pathology
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- Endothelial Cells Create a Stem Cell Niche in Glioblastoma by Providing NOTCH Ligands That Nurture Self-Renewal of Cancer Stem-Like Cells
- (2011) T. S. Zhu et al. CANCER RESEARCH
- Human Glioma Growth Is Controlled by MicroRNA-10b
- (2011) G. Gabriely et al. CANCER RESEARCH
- Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions
- (2011) Rajesh Ambasudhan et al. Cell Stem Cell
- Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study
- (2011) Aaron D. Schimmer et al. Clinical Lymphoma Myeloma & Leukemia
- Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
- (2011) Clare V LeFave et al. EMBO JOURNAL
- miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion
- (2011) Adam Fowler et al. EUROPEAN JOURNAL OF CANCER
- Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses
- (2011) M. N. Cabili et al. GENES & DEVELOPMENT
- MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2
- (2011) Xie-Feng Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth
- (2011) Jianpeng Wang et al. MOLECULAR BIOLOGY REPORTS
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
- (2011) A. Carpentier et al. NEURO-ONCOLOGY
- Trabedersen to target transforming growth factor- : when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)
- (2011) W. Wick et al. NEURO-ONCOLOGY
- Convection-enhanced delivery of a transforming growth factor- 2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)
- (2011) M. C. Chamberlain NEURO-ONCOLOGY
- Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo
- (2011) A. B. Gaur et al. NEURO-ONCOLOGY
- Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas
- (2011) H-J Kwak et al. ONCOGENE
- miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ
- (2011) C Quintavalle et al. ONCOGENE
- Reduced Expression of Brain-Enriched microRNAs in Glioblastomas Permits Targeted Regulation of a Cell Death Gene
- (2011) Rebecca L. Skalsky et al. PLoS One
- Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells
- (2010) Xiao Yue et al. BRAIN RESEARCH
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
- (2010) C. O. Marian et al. CLINICAL CANCER RESEARCH
- Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines
- (2010) Joseph George et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
- (2010) Xuan Zhou et al. LABORATORY INVESTIGATION
- MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
- (2010) Chun-Zhi Zhang et al. Molecular Cancer
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
- (2010) U. Bogdahn et al. NEURO-ONCOLOGY
- NFKBIADeletion in Glioblastomas
- (2010) Markus Bredel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficient in vivo microRNA targeting of liver metastasis
- (2010) C Huynh et al. ONCOGENE
- De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures
- (2010) A Ernst et al. ONCOGENE
- PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73
- (2010) N Rökaeus et al. ONCOGENE
- Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship
- (2010) H. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Locked nucleic acids (LNAs) reveal sequence requirements and kinetics of Xist RNA localization to the X chromosome
- (2010) K. Sarma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells
- (2010) S. K. Das et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- (2009) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
- (2009) Takuya Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC
- (2009) Takashi Sasayama et al. INTERNATIONAL JOURNAL OF CANCER
- 5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen
- (2009) Susan O'Brien et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma
- (2009) Asher A. Chanan-Khan et al. LEUKEMIA & LYMPHOMA
- MicroRNA-mediated switching of chromatin-remodelling complexes in neural development
- (2009) Andrew S. Yoo et al. NATURE
- The transcriptional network for mesenchymal transformation of brain tumours
- (2009) Maria Stella Carro et al. NATURE
- Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts
- (2009) J. Graeme Hodgson et al. NEURO-ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations
- (2009) Cameron Brennan et al. PLoS One
- Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1
- (2009) R. Ueda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
- (2009) Miguel F. Segura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
- Analysis of the IDH1 codon 132 mutation in brain tumors
- (2008) Jörg Balss et al. ACTA NEUROPATHOLOGICA
- miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
- (2008) Joachim Silber et al. BMC Medicine
- Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth
- (2008) P Pu et al. CANCER GENE THERAPY
- microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma
- (2008) B. Kefas et al. CANCER RESEARCH
- Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal
- (2008) J. Godlewski et al. CANCER RESEARCH
- MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell Survival
- (2008) R. Medina et al. CANCER RESEARCH
- miR-21: a small multi-faceted RNA
- (2008) Anna M. Krichevsky et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a
- (2008) Yu Zhang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma
- (2008) Jessica Pierson et al. JOURNAL OF NEURO-ONCOLOGY
- Spinal muscular atrophy
- (2008) Mitchell R Lunn et al. LANCET
- MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
- (2008) G. Gabriely et al. MOLECULAR AND CELLULAR BIOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
- (2008) Neri Mercatelli et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now